Assessment of neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan.
A total of 368 blood specimens were resampled from a serum collection containing 2914 blood samples which were collected by a random sampling in Taiwan in 1991. The plaque reduction neutralization test was applied to evaluate the neutralizing ability to two strains of Japanese encephalitis viruses, i.e. Nakayama (the present vaccine strain) and JE5 (a Taiwan isolate). The result revealed that antibodies against JE virus were present in each stratified age group. Antibody positive rates were both highest in the group older than 70 years although the lowest rates were located in different groups. In addition, the result showed that the immunogenicity potency of the antibody induced by the vaccine strain did not have a good coverage against JE5. The rate of neutralizing antibodies above the level of protective efficacy of the present vaccine was limited as low as 37.93%. Efficacy of the vaccine used at present was apparently not efficient. Consideration of a more promising vaccine may be necessary.
Shyu
W R
WR
Institute of Preventive Medicine, National Defense Medical Center, Sanhsia, Taipei, Taiwan.
Wang
Y C
YC
Chin
C
C
Chen
W J
WJ
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis*; D002478:Cells, Cultured; D003429:Cross Reactions / Q000276:immunology; D004664:Encephalitis Virus, Japanese / Q000254:growth & development / Q000276:immunology*; D004672:Encephalitis, Japanese / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D009500:Neutralization Tests; D013624:Taiwan / Q000453:epidemiology; D014612:Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D014612:Vaccines